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Genetic Variation in the Leptin Receptor Gene,
Leptin, and Weight Gain in Young Dutch Adults
Caroline T.M. van Rossum,* Barbara Hoebee,† Marleen A. van Baak,‡ Monica Mars,§ Wim H.M. Saris,‡ and
Jacob C. Seidell*
Abstract
VAN ROSSUM, CAROLINE T.M., BARBARA HOEBEE,
MARLEEN A. VAN BAAK, MONICA MARS, WIM
H.M. SARIS, AND JACOB C. SEIDELL. Genetic variation
in the leptin receptor gene, leptin, and weight gain in young
Dutch adults. Obes Res. 2003;11:377–386.
Objective: To investigate the association between leptin
levels, polymorphisms in the leptin receptor (LEPR) gene,
and weight gain.
Research Methods and Procedures: From two large pro-
spective cohorts in The Netherlands (n  17,500), we
compared the baseline leptin of 259 subjects who had
gained an average of 12.6 kg (range 5.5 to 33 kg) with 277
subjects who kept stable weight (range2.6 to 3.1 kg) after
a mean follow-up of 6.8 years. Three polymorphisms in the
LEPR gene (Lys109Arg, Gln223Arg, and Lys656Asn) were
determined.
Results: Weight gainers had significantly higher baseline
leptin levels than those who kept stable weight (odds ra-
tio  1.27, 95% confidence interval 1.1 to 1.5, per SD
increase in loge-transformed leptin). Weight gainers with
the Arg109 or the Arg223 alleles had higher leptin levels
compared with the noncarriers of these alleles. Only among
men, the association between leptin and weight gain tended
to be stronger among those with an Arg223 allele compared
with those without this mutation.
Discussion: Relatively high leptin levels predict weight
gain, suggesting that leptin resistance plays a role in the
development of obesity in the general population. Higher
leptin levels for those with a Lys109Arg or Gln223Arg
mutation (or a linked other marker) may imply that these
subjects have a modified functional leptin receptor. How-
ever, the role of these mutations on weight gain is limited.
Key words: weight gain, leptin, polymorphisms, leptin
receptor, prospective study
Introduction
Leptin is a hormone that is mainly produced by adipose
tissue and binds to receptors in the hypothalamus (1). The
discovery of mutations in the leptin gene and its receptor in
rodent models of obesity (e.g., ob/ob and db/db mice) and in
rare cases of human morbid obesity indicates that leptin
functions as an afferent signal in a negative feedback loop
that regulates energy balance (2–6). However, the role of
leptin and its receptor in the development of obesity in the
general population is less clear. The etiology of common
obesity is more complex, because many genetic, metabolic,
and environmental factors might interact, but it remains
possible that leptin or its receptor is involved.
Particular mutations in the leptin gene in animal models
and humans lead to leptin deficiency and extreme obesity
(2–6). For common obesity, a similar, but weaker, negative
association between leptin and weight might be found.
Common obesity, however, is characterized by high, rather
than low, levels of leptin, and it has been suggested that
obese subjects may be leptin resistant (7). Several mecha-
nisms may contribute to leptin resistance. Diminished leptin
receptor signaling due to a mutant leptin receptor might be
one of the explanations (8). This has been demonstrated in
db/db mice and some severely obese humans who are ho-
mozygous for a mutation in the leptin receptor, who have
extremely high leptin levels (6). Such mutations are ex-
tremely rare and cannot be responsible for obesity in the
general population. However, this observation suggests that
other, less severe disruptions of the normal leptin-signaling
pathway might be involved in the development of common
obesity (9). Therefore, it is conceivable that more common
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mutations in the leptin receptor (LEPR)1 gene could modify
the function of the leptin receptor in such a way that they
affect leptin levels in the general population.
We selected, from a large population study, subjects who
gained weight in a follow-up period of, on average, 7 years
and subjects who kept stable weight. We investigated
whether the baseline leptin levels predicted weight gain. In
addition, we investigated the association between three
polymorphisms in the LEPR gene and leptin levels and the
modification of the association between leptin and weight
gain by these polymorphisms.
Research Methods and Procedures
Subjects were selected from participants in cardiovascu-
lar monitoring projects that have been carried out in two
towns of The Netherlands, Maastricht and Doetinchem. The
design and rationale of the selection of the participants has
been described in more detail elsewhere (10). In short, the
baseline measurements occurred between 1987 and 1997 at
the Municipal Health Services (11). In Doetinchem, a sec-
ond measurement occurred 6 years after the baseline mea-
surement (1993 to 1997), again at the Municipal Health
Service. In Maastricht, the follow-up measurements were
ascertained in 1998 by means of a self-administered ques-
tionnaire. To exclude, as much as possible, other potential
influences on weight change, subjects from these two co-
horts (n  17,743) who were dieting, were high alcohol
consumers, were pregnant, had changed their smoking sta-
tus recently, suffered from serious illnesses, and those of 40
years and above were excluded. Furthermore, those with a
follow-up of less than 4 years, those without an informed
consent, a blood sample, or data on weight were also ex-
cluded. From the remaining group (19% of the original
sample), we selected “high weight gainers” by taking the
top decile of the distribution of average weight gain per year
(1.4 and 1.3 kg/year for the cohorts of Doetinchem and
Maastricht, respectively). We randomly selected an equal
sized group of subjects (stable weight) whose weight
remained relatively constant (range: 0.3 to 0.3 kg/year).
The non-weight gainers were frequency matched for town,
sex, age, and smoking status with the weight gainers. Be-
cause menopause can be a confounder of the association
between leptin and weight gain (12,13), we also excluded in
these analyses seven female subjects who had an operation
on the womb or ovaries or did not have a period in the last
12 months. Data on leptin levels and DNA polymorphisms
were available for 259 weight gainers and 277 non-weight
gainers.
Measurements
The examinations at baseline and the second measure-
ment included physical examinations, e.g., anthropometric
measurements, a self-administered questionnaire, and blood
sampling. However, for those in Maastricht, the second
measurement included only a self-administered question-
naire.
Anthropometric Measures. Weight at baseline was mea-
sured without shoes and wearing light indoor clothing. For
all participants in Doetinchem, weight was remeasured after
6 years in the same season as in the initial measurement. For
the participants from Maastricht, it is likely that subjects
wore less clothing when measured at home compared with
the measurement at the health center. To allow for the
weight of clothing, we added 1.5 kg at the self-reported
weight. This amount was based on some measurements of
the clothes by investigators at the health center. Body mass
index (BMI) was calculated as weight divided by squared
height. Weight gain was defined as the difference between
the weight at baseline and the weight at the second exam-
ination. Because the period of follow-up varied (6 years in
Doetinchem and 4.0 to 11.3 years in Maastricht), we calcu-
lated the average weight gain per year.
Characteristics of the Study Population. The question-
naires at baseline and/or follow-up provided information
about history of chronic diseases, alcohol consumption,
cigarette smoking, pregnancy, and educational level. Smok-
ing history was categorized into “nonsmokers” (those who
had never smoked or stopped smoking more than 5 years
before the start of the study), “smokers” (subjects who
reported to be a current smoker at baseline as well as at the
second measurement), and the remaining group (subjects
who had changed their smoking habits during the two
measurements or stopped smoking5 years before the start
of the study). This last category was an exclusion category.
The educational level, a measure for socioeconomic status,
was classified into three categories: low (primary school,
lower vocational/general education), medium (intermediate/
higher general education, intermediate vocational educa-
tion), and high (higher vocational education, university).
Leptin. Leptin concentrations were measured in the base-
line nonfasting plasma samples, which had been stored at
20 °C for 6 to 14 years. These measurements were done
in duplicate by radioimmunoassay (HL-81K kit, Linco Re-
search Inc., St. Charles, MO).
Genotyping. We determined three polymorphisms in
the LEPR gene: a lysine to alanine substitution at codon
109 (Lys109Arg), a glutamine to arginine substitution at
codon 223 (Glu223Arg), and lysine to asparagine at codon
656 (Lys656Asn) (14). Genotyping was done using poly-
merase chain reaction-restriction fragment length polymor-
phism analyses. To increase the power of the statistical
analyses, for each polymorphism, heterozygotes were com-
bined with the smallest group of homozygotes. For exam-
ple, subjects with the Lys109/Arg109 or the Arg109/
Arg109 genotype of the LEPR gene were combined and
compared with those with the Lys109/Lys109 genotype.1 Nonstandard abbreviations: LEPR, leptin receptor gene; BMI, body mass index.
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Data Analyses
Differences in characteristics between high weight gain-
ers and non-weight gainers were analyzed with chi-square
tests and Student’s t tests. Because leptin concentrations and
weight gain were not normally distributed, these variables
were natural logarithmically transformed (loge). The asso-
ciation between leptin and weight gain was performed in
three ways. First, leptin levels adjusted for baseline BMI
were evaluated according to weight gain (yes/no) using
analyses of covariance. The (adjusted) logarithmically
transformed leptin values were transformed back to normal
values. Second, logistic regression analyses were carried out
to investigate the association between leptin (per SD in-
crease in the logarithm) and weight gain (yes/no). In addi-
tion, among weight gainers, regression analyses were per-
formed to investigate the BMI-adjusted association between
leptin and weight gain per year.
Geometric means of leptin levels according to each poly-
morphism in the LEPR gene were also calculated on the
basis of analysis of covariance. For each polymorphism
separately, we also analyzed these levels according to com-
binations of two polymorphisms. These analyses were per-
formed separately in weight gainers and those with stable
weight.
Finally, we tested whether the association between leptin
and weight gain (yes/no) was modified by the genotyping of
the LEPR gene, by adding the genotype and the interaction
term between these genetic factors and leptin to the logistic
regression models.
All these associations were adjusted for baseline BMI.
Furthermore, all analyses were done separately in men and
women and in men and women combined (adjusted for sex),
and they were performed using the statistical package SAS
(version 8.1; SAS Institute, Cary, NC).
Results
The characteristics of the study population are shown in
Table 1. Subjects were, on average, 29.3 years (range 20 to
40) old and had a baseline BMI of 23.5 kg/m2 (SD  3.1).
Subjects with high weight gain increased, on average, 12.6
kg (range 5.5 to 32.9 kg) corresponding with an increase in
BMI of 4 units, whereas those with “stable” weight gained,
on average, 0.5 kg (range 2.6 to 3.1 kg) during a mean
follow-up of 6.8 years. At baseline, weight gainers already
had a higher body weight and height (in men) compared
with the nonweight gainers. BMI was not significantly
different between the two groups (p  0.40 and 0.12 for
men and women, respectively). Weight gainers did not
significantly differ in educational level from non-weight
gainers.
Table 1. Characteristics of the study population [means (SD) or percentages]
Men Women
High weight gain
(n  126)
Stable weight
(n  134) p value
High weight gain
(n  133)
Stable weight
(n  143) p value
At baseline
Age (years) 28.2 (5.9) 28.9 (5.6) * 30.1 (5.9) 29.9 (6.0) *
Weight (kg) 79.4 (10.9) 76.6 (10.0) 0.03 66.2 (11.1) 63.4 (8.1) 0.02
Height (cm) 1.82 (0.07) 1.80 (0.07) 0.02 1.68 (0.07) 1.67 (0.06) 0.11
BMI (kg/m2) 24.0 (3.0) 23.7 (2.8) 0.40 23.5 (3.7) 22.9 (2.8) 0.12
Smoking (%) 36.5 35.1 * 33.8 34.3 *
Socioeconomic status
(%)
Low 46.8 41.8 54.9 46.9
Medium 42.1 38.8 33.1 32.9
High 11.1 19.4 0.17 12.0 20.3 0.15
At end of follow-up
Follow-up time (years) 6.9 (1.7) 7.2 (1.9) 0.24 6.7 (1.5) 6.8 (1.6) 0.51
Weight (kg) 92.0 (11.6) 77.0 (10.0) * 79.1 (12.4) 63.9 (8.1) *
Weight gain (kg/year) 1.86 (0.54) 0.06 (0.17) * 1.90 (0.46) 0.08 (0.17) *
BMI (kg/m2) 27.9 (3.3) 23.9 (2.8) * 28.0 (4.0) 23.1 (2.8) *
* p Values not given; criteria for group selection.
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Leptin and Weight Gain
Leptin levels of women were higher than those of men
(median 9.7 and 3.0 g/L, respectively). These levels were
strongly correlated with baseline BMI levels (r  0.60 and
0.72 for men and women, respectively). Table 2 shows the
geometric means of the leptin levels for the weight gainers
and those who kept stable weight. At baseline, weight
gainers had significantly higher leptin levels than non-
weight gainers, 3.4 vs. 3.0 and 10.6 vs. 9.2 g/L for men
and women, respectively. These differences could partly be
explained by the variation in BMI as an indicator for fat
mass. For men, the difference in leptin levels remained
borderline statistically significant after adjustment for BMI.
The odds ratio for weight gain according to one SD increase
in the logarithm of leptin levels was 1.27 (95% confidence
interval, 1.07 to 1.51) for the total group of subjects. After
adjustment for BMI, this was 1.28 (1.01 to 1.61) for the total
group (see Table 3). Table 4 shows the association between
leptin and weight gain among the weight gainers. For the
male weight gainers, higher leptin levels tended to be asso-
ciated with more weight gain (p  0.02), whereas among
female weight gainers, no association was observed.
Table 2. Leptin levels for weight gainers and those who kept stable weight
Total median
(range)
High weight gain,
geometric mean
(95% confidence
interval)
Stable weight,
geometric mean
(95% CI) p value
Men n  260 n  126 n  134
Leptin (g/L) 3.0 (1.1 to 15.5) 3.4 (3.1 to 3.7) 3.0 (2.7 to 3.3) 0.06
Leptin, adjusted for baseline BMI (g/L) 3.3 (3.1 to 3.6) 3.0 (2.8 to 3.3) 0.08
Women n  276 n  133 n  143
Leptin (g/L) 9.7 (1.9 to 74) 10.6 (9.6 to 11.8) 9.2 (8.3 to 10.2) 0.05
Leptin, adjusted for baseline BMI (g/L) 10.2 (9.5 to 10.9) 9.6 (8.9 to 10.3) 0.25
Men and women n  536 n  259 n  277
Leptin (g/L)* 5.8 (1.1 to 74) 6.0 (5.6 to 6.5) 5.3 (4.9 to 5.6) 0.007
Leptin, adjusted for baseline BMI (g/L)* 5.8 (5.5 to 6.1) 5.4 (5.1 to 5.7) 0.04
* (Also) adjusted for sex.
Table 3. Odds ratios for the risk of weight gain (yes/no) from baseline to follow-up for SD increase in
loge-transformed leptin levels
Men Women Total
SD of the
natural
logarithm
Odds ratio
(95%
confidence
interval)
SD of the
natural
logarithm
Odds ratio
(95%
confidence
interval)
Odds ratio
(95%
confidence
interval)*
n  260 n  276 n  536
Risk of weight gain per SD increase
in loge-transformed leptin levels 0.54
1.27
(0.99 to 1.63) 0.62
1.27
(1.00 to 1.61)
1.27
(1.07 to 1.51)
Risk of weight gain per SD increase
in loge-transformed leptin levels,
adjusted for baseline BMI
1.32
(0.97 to 1.80)
1.23
(0.87 to 1.74)
1.28
(1.01 to 1.61)
* Also adjusted for sex.
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Leptin and Polymorphisms in LEPR Gene. Table 5 shows
the geometric means of leptin according to the polymor-
phisms in the LEPR gene. In addition, the contrast in leptin
between carriers and noncarriers of combinations of two
mutations is shown. Statistically significant differences in
leptin levels were observed among only the weight gainers.
Carriers of the Arg109 allele or the Arg223 allele tended to
have higher leptin levels compared with noncarriers of these
alleles, p  0.02 and 0.03, respectively. For carriers of the
Arg109 and Arg223 alleles, leptin levels were 10% to 20%
higher compared with the noncarriers of these two alleles
(6.6 vs. 5.6 g/L, p  0.02). Differences in leptin levels
according to the polymorphism at position 656 of the LEPR
gene were not statistically significant. However, male
weight gainers with either the Arg109 allele or the Arg223
allele and the Asn656 allele have (borderline) significantly
higher leptin levels compared with those with none of these
alleles (4.0 vs. 3.0 g/L, p  0.06; or 3.6 vs. 2.6 g/L, p 
0.02).
Leptin and Polymorphism in LEPR Gene and Weight
Gain. Table 3 showed that the risk of being a weight gainer
increases with higher baseline levels of leptin. If polymor-
phisms in the leptin receptor play a role in the leptin
signaling, it is likely that the association between leptin and
weight gain is modified by mutations in the LEPR gene.
However, Table 6 shows that the associations between
leptin and risk for weight gain were not clearly modified by
these mutations. Only among men, the association tended to
be stronger among those with an Arg223 allele compared
with those without this mutation.
Discussion
In our study population, leptin levels adjusted for BMI
were positively associated with weight gain; those with
higher leptin levels had a higher risk for gaining weight.
Furthermore, among those who gained weight, baseline
leptin levels were higher for carriers of the Arg109 or
Arg223 mutations in the leptin receptor. The associations
were clearer among men than among women. Among men,
the association between baseline leptin and weight gain was
modified by the Gln223Arg mutation in the LEPR gene.
To appreciate these findings, certain aspects of the study
must be considered. An advantage of our study was our
prospective design to study the association between leptin
and weight gain. Because leptin might affect weight gain,
and a higher weight could, in turn, influence leptin levels,
cross-sectional and longitudinal studies on the role of leptin
in the etiology of obesity can generate completely opposite
conclusions (15).
Secondly, the issue of potential selection bias must be
considered. The participation rate in the original cohort was
50% (11). It is unlikely, however, that there was selective
participation by baseline leptin level or genotype among the
weight gainers and non-weight gainers. This is supported by
the fact that the distributions of the genotypes were in
Hardy-Weinberg Equilibrium.
Thirdly, our findings could be affected by misclassifica-
tion problems. For the subjects from Maastricht, the weights
at the end of the follow-up were self-reported. Because
errors in self-reported weight increase with the magnitude
of overweight, this misclassification was probably not ran-
domly distributed (16). However, we assumed that the dis-
tinction between weight gainers and those who kept stable
weight and the ranking in weight gainers were hardly af-
fected by this.
Leptin levels were measured in nonfasting blood samples
that were not taken for all subjects at the same time of the
day. Because leptin concentrations in humans show a clear
diurnal pattern, and this pattern is entrained to meal timing
(17), leptin levels measured in our study might be affected
by this pattern. However, it is unlikely that these factors
differed for weight gainers and weight keepers, or that they
were associated with the genotype of the LEPR gene. This
is confirmed in the follow-up measurements of a subsample
of 286 subjects. In this subsample, time of blood sampling
or time of last eating was not significantly associated with
leptin levels, nor did the weight gainers and weight keepers
differ in these factors. Because several studies found that
Table 4. Average loge-transformed weight gain per year from baseline to follow-up per SD increase in loge-
transformed leptin levels among weight gainers
Men (n  126) Women (n  133)
 (95% CI) p value  (95% confidence interval) p value
Average loge-transformed
weight gain per year 0.048 (0.007, 0.089) 0.02 0.002 (0.041 to 0.037) 0.90
Average loge-transformed
weight gain per year,
adjusted for baseline BMI 0.053 (0.002, 0.104) 0.04 0.001 (0.063, 0.062) 0.98
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leptin concentrations fluctuate according to the phase of the
menstrual cycle (18,19), and blood samples were not taken
for all women at the same time in the cycle, it is likely that
this variation has diluted our results. This might explain the
clearer findings in men compared with those among
women.
Furthermore, the matching factors could have con-
founded our results. Fortunately, these biases were of minor
importance because similar results were found with and
without adjustment for these factors.
At baseline, female weight gainers had slightly higher
BMI values compared with those who kept stable weight.
Because persons with more fat mass have higher leptin
levels, and fat mass also independently affects the risk of
weight gain due to e.g., environmental factors, we adjusted
the associations by taking BMI into the analyses to control
Table 5. Leptin levels (g/L) according to polymorphisms in the LEPR gene, adjusted for baseline BMI
Men Women Total
High weight gain Stable weight High weight gain Stable weight High weight gain Stable weight
n
Geometric
mean (95%
confidence
interval) n
Geometric
mean (95%
confidence
interval) n
Geometric
mean (95%
confidence
interval) n
Geometric
mean (95%
confidence
interval) n
Geometric
mean (95%
confidence
interval)* n
Geometric
mean (95%
confidence
interval)*
LEPR Lys109Arg
Lys109/Lys109 70 3.2 (2.9 to 3.6) 73 3.0 (2.7 to 3.3) 70 10.0 (9.1 to 11.1) 70 9.1 (8.3 to 10.1) 140 5.8 (5.4 to 6.2) 143 5.3 (5.0 to 5.7)
Arg109/ 56 3.7 (3.3 to 4.1) 61 3.0 (2.7 to 3.3) 63 11.3 (10.3 to 12.6) 73 9.3 (8.4 to 10.2) 119 6.5 (6.0 to 7.1) 134 5.4 (5.0 to 5.8)
p value 0.11 0.99 0.11 0.86 0.02 0.87
LEPR Gln223Arg
Gln223/Gln223 43 3.1 (2.7 to 3.5) 43 3.0 (2.6 to 3.4) 38 10.0 (8.7 to 11.4) 42 8.9 (7.8 to 10.1) 81 5.6 (5.1 to 6.2) 85 5.2 (4.8 to 5.7)
Arg223/ 83 3.6 (3.3 to 4.0) 91 3.0 (2.8 to 3.3) 95 10.9 (10.0 to 11.9) 101 9.3 (8.6 to 10.1) 178 6.4 (6.0 to 6.8) 192 5.4 (5.1 to 5.7)
p value 0.05 0.84 0.27 0.55 0.03 0.53
LEPR Lys656Asn
Lys656/Lys656 77 3.3 (3.0 to 3.7) 89 2.9 (2.7 to 3.1) 95 10.6 (9.7 to 11.6) 93 8.7 (7.7 to 9.8) 172 6.0 (5.6 to 6.4) 182 5.3 (4.9 to 5.7)
Asn656/ 49 3.6 (3.1 to 4.0) 45 3.2 (2.9 to 3.6) 38 10.6 (9.2 to 12.2) 50 9.5 (8.7 to 10.3) 87 6.3 (5.7 to 6.9) 95 5.4 (5.0 to 5.8)
p value 0.40 0.14 0.97 0.23 0.49 0.89
Combination of two
polymorphisms†
LEPR Lys109Arg
and Gln223Arg
Lys109/Lys109 &
Gln223/Gln223 42 3.1 (2.7 to 3.5) 43 3.0 (2.6 to 3.4) 38 10.0 (8.7 to 11.4) 40 8.7 (7.7 to 10.0) 80 5.6 (5.1 to 6.2) 83 5.2 (4.7 to 5.7)
Arg109/ &
Arg223/ 55 3.7 (3.3 to 4.1) 61 3.0 (2.7 to 3.3) 63 11.1 (10.2 to 12.6) 71 9.2 (8.3 to 10.1) 118 6.6 (6.1 to 7.1) 132 5.3 (5.0 to 5.7)
p value 0.05 0.90 0.05 0.54 0.02 0.59
LEPR Lys109Arg
and Lys656Asn
Lys109/Lys109 &
Lys656/Lys656 33 3.0 (2.6 to 3.5) 42 2.7 (2.4 to 3.1) 43 9.8 (8.6 to 11.1) 35 9.9 (8.6 to 11.4) 76 5.5 (5.0 to 6.1) 77 5.3 (4.8 to 5.8)
Arg109/ &
Asn656/ 12 4.0 (3.1 to 5.2) 14 2.9 (2.4 to 3.6) 11 11.0 (8.5 to 14.2) 15 9.2 (7.4 to 11.4) 23 6.9 (5.7 to 8.2) 29 5.3 (4.6 to 6.2)
p value 0.06 0.63 0.43 0.59 0.04 0.92
LEPR Gln223Arg
and Lys656Asn
Gln223/Gln223 &
Lys656/Lys656 19 2.6 (2.1 to 3.2) 18 2.5 (2.1 to 3.0) 23 9.7 (8.1 to 11.6) 16 10.1 (8.2 to 12.4) 42 5.1 (4.5 to 5.9) 34 5.0 (4.4 to 5.8)
Arg223/ &
Asn656/ 25 3.6 (3.1 to 4.3) 20 3.0 (2.5 to 3.6) 23 10.8 (9.1 to 129) 24 9.2 (7.7 to 10.9) 48 6.4 (5.6 to 7.2) 44 5.4 (4.8 to 6.1)
p value 0.02 0.12 0.41 0.50 0.02 0.46
* Also adjusted for sex.
† Based on analyses in which all four combinations of these two polymorphisms were included, only the results of these two extreme groups
are shown.
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for the confounding. BMI is not a perfect measure for the
amount of body fat percentage, but in Dutch adults they are
highly correlated (r  0.75) (20). Therefore, it is possible
that the observed differences between weight gainers and
weight keepers are still partly caused by residual confound-
ing of body fat percentage. Although this confounding may
have affected the association between leptin and weight
gain, it is unlikely that it has affected our conclusion that
leptin predicts weight gain. In addition, it remains possible
that our association can be explained by other unknown and
confounding factors that influence both weight gain and
leptin.
Rodent models of obesity (e.g., ob/ob mice) and some
human cases of severe obesity are leptin deficient due to a
rare mutation in the leptin gene (2,5). Treatment with leptin
results in a decrease in food intake and body weight (21–
24). Therefore, we expected that for common obesity, a
similar, but weaker, negative association between leptin and
Table 6. Odds ratio for the risk of weight gain from baseline to follow-up per SD increase in loge-transformed
leptin levels according to polymorphisms in the LEPR gene, adjusted for baseline BMI
Men Women Total
n
Odds ratio
(95% confidence
interval) n
Odds ratio
(95% confidence
interval) n
Odds ratio
(95% confidence
interval)
LEPR Lys109Arg
Lys109/Lys109 143 1.00 (0.49 to 2.04) 140 1.25 (0.66 to 2.37) 283 1.26 (0.87 to 1.83)
Arg109/ 117 1.49 (0.98 to 2.28) 136 1.23 (0.80 to 1.90) 253 1.30 (0.99 to 1.70)
p interaction 0.39 0.97 0.89
LEPR Gln223Arg
Gln223/Gln223 86 0.58 (0.24 to 1.38) 80 1.04 (0.46 to 2.39) 166 0.98 (0.63 to 1.54)
Arg223/ 174 1.61 (1.11 to 2.33) 196 1.26 (0.87 to 1.83) 370 1.36 (1.06 to 1.74)
p interaction 0.046 0.68 0.18
LEPR Lys656Asn
Lys656/Lys656 166 1.71 (0.84 to 3.48) 188 1.12 (0.61 to 2.04) 354 1.50 (1.05 to 2.14)
Asn656/ 94 1.14 (0.72 to 1.78) 88 1.28 (0.79 to 2.09) 182 1.15 (0.86 to 1.54)
p interaction 0.41 0.75 0.26
Combinations of two
polymorphisms†
LEPR Lys109Arg and Gln223Arg
Lys109/Lys109 & Gln223/Gln223 85 0.87 (0.56 to 1.36) 78 1.25 (0.78 to 1.99) 163 1.03 (0.75 to 1.42)
Arg109/ & Arg223/ 116 1.43 (0.98 to 2.09) 134 1.31 (0.93 to 1.85) 250 1.36 (1.06 to 1.76)
p interaction 0.10 0.87 0.18
LEPR Lys109Arg and Lys656Asn
Lys109/Lys109 & Lys656/Lys656 75 1.28 (0.79 to 2.06) 78 1.06 (0.65 to 1.73) 153 1.17 (0.84 to 1.65)
Arg109/ & Asn656/ 26 1.54 (0.66 to 3.60) 26 0.92 (0.44 to 1.92) 52 1.17 (0.65 to 1.94)
p interaction 0.71 0.75 0.90
LEPR Gln223Arg and Lys656Asn
Gln223/Gln223 & Lys656/Lys656 37 0.95 (0.44 to 2.08) 39 0.88 (0.46 to 1.70) 76 0.94 (0.57 to 1.54)
Arg223/ & Asn656/ 45 1.48 (0.79 to 2.76) 47 1.14 (0.67 to 1.92) 92 1.26 (0.85 to 1.88)
p interaction 0.39 0.55 0.36
p Interaction, test of p value of the interaction term between leptin and the specific genotype.
* Also adjusted for sex.
† Subjects with other genotypes were excluded from these analyses.
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weight would be observed. However, we found no evidence
for the hypothesis that relatively low leptin levels predis-
pose to weight gain. In contrast, we observed that those with
higher leptin levels tended to have an increased risk for
gaining weight compared with those with low levels.
Our finding is in contrast with a study in 36 obese Pima
Indians; those with relatively low leptin levels were more
prone to gain weight compared with those with higher leptin
levels (25). Also, Lindroos et al. found a negative associa-
tion between leptin and weight gain, but only in a small
subgroup of 24 very obese Swedes without a history of
parental obesity (26). However, other prospective studies in
more moderately obese populations found no association
(27–29) or also a positive (30,31) association, as in our
study, between leptin and weight gain. There are several
possible explanations for these differences. First, it is pos-
sible that the association between leptin and weight gain is
modified by the degree of obesity. Secondly, in the study in
Pima Indians, adjustments were made for more accurate
measures of body fat percentage (assessed by hydrodensi-
tometry) than BMI. Thirdly, other population characteris-
tics that were different across studies may explain the
inconsistencies.
Because db/db mice and some humans with leptin resis-
tance due to a defect in their leptin receptor are severely
obese and have high plasma leptin levels (6), we expected a
similar, but weaker, association between leptin and weight
gain in our population. Our observation that weight gainers
had significantly higher baseline leptin concentrations than
weight keepers is consistent with this hypothesis that leptin
resistance contributes to weight gain in a general white
population.
Some other studies reported leptin levels according to
mutations in the LEPR gene (32–34). Only Chagnon et al.
also reported higher leptin levels after adjustment for fat
mass among middle aged men with an Arg223 allele (34).
Most of the other associations found were not independent
of BMI and were performed in very small groups, in over-
weight and obese, nonwhite, or postmenopausal women,
which may explain the inconsistency in these results (33).
Our findings of increased leptin levels in carriers of the
Arg109 allele or the Gln223 allele of the LEPR gene com-
pared with those in the noncarriers of these alleles suggest
that for these variants, the signaling of leptin is impaired.
However, so far as we know, no studies have been per-
formed on the affected functionality of this protein due to
these mutations or other linked markers. Whether its func-
tionality is indeed impaired needs further investigation.
A defective leptin receptor due to mutations in the gene is
one of the explanations for a positive association between
leptin and weight gain. Arch et al. suggested that in most
cases, leptin concentrations are raised not only because of
genetic variability, but also because of other opposing
forces that promote obesity (35). Our results support this
idea, because weight gainers differed in some aspects of
dietary habits and physical activity from non-weight gainers
(10), and weight gainers had higher leptin levels. It is likely
that variation in genetic factors and lifestyle factors, such as
physical activity and metabolic factors (36–38), explains
the inconsistency in the reported associations between leptin
and weight gain.
Nevertheless, our data suggest that persons with the
Arg109 allele or the Gln223 allele are more prone to this
influence of other leptin-influencing factors. Seeing the
different associations found among men between leptin and
weight gain across the genotypes, it is likely that these
polymorphisms in the LEPR gene have some small impact
on weight gain. That this is a small impact is not surprising
because weight gain is influenced by several factors and
pathways. However, in the same study population, a weak
association between these polymorphisms and weight gain
was observed among women for only the Lys109Arg geno-
type; women with the Lys109/Lys109 polymorphism had a
lower risk to gain weight (10). These contrasting findings
suggest that the role of these polymorphisms on weight gain
is very complicated and not yet clear. Also, meta-analyses
have shown that there is no clear evidence that these poly-
morphisms are associated with BMI (39). They also argue
that these alleles can still have an impact on weight, but
these effects can be compensated by other (genetic) factors
and pathways. Therefore, further studies on the influence of
these alleles on intermediate phenotypes instead of weight
could help to elucidate the role of these alleles on the
development of obesity.
Thus, we conclude that in white subjects, relatively high
leptin levels seem to predict subsequent weight gain. Fur-
thermore, Lys109Arg or Gln223Arg polymorphisms in the
LEPR gene are associated with higher leptin levels, suggest-
ing that these polymorphisms (or markers that are in linkage
disequilibrium with these polymorphisms) lead to leptin
resistance. However, the role of these mutations on weight
gain is limited.
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